Evaluating cognitive function in patients with lower grade astrocytomas using advanced brain imaging techniques.
Multimodality Neuroimaging Evaluation of Cognitive Functioning in Lower Grade Astrocytoma
This study is looking at how special brain scans can help us understand how lower grade astrocytomas affect thinking and memory in patients, with the hope of finding ways to improve their quality of life and support those who might struggle with cognitive issues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10910045 on NIH RePORTER |
What this research studies
This research investigates how advanced brain imaging techniques can assess cognitive functioning in patients with lower grade astrocytomas. By utilizing a combination of metabolic imaging, diffusion, perfusion, and functional MRI, the study aims to identify cognitive impairments and their relationship to tumor characteristics and treatment history. The goal is to provide a better understanding of how these tumors affect brain function and quality of life, potentially leading to targeted interventions for those at risk of cognitive decline.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with lower grade astrocytomas who may be experiencing cognitive impairments.
Not a fit: Patients with other types of brain tumors or those without cognitive issues related to their condition may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cognitive assessments and tailored interventions for patients with lower grade astrocytomas, enhancing their quality of life.
How similar studies have performed: Previous research has shown promising results using similar multimodal imaging approaches to assess cognitive function in brain tumor patients, indicating potential for success in this study.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Li, Yan — University of California, San Francisco
- Study coordinator: Li, Yan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.